Cargando…
Prevention and management of health products shortages by the French national agency (ANSM), 10 years of experience
Shortages of drugs and medical devices have tended to increase in France and worldwide, with consequences for patients and healthcare professionals. Preventing shortages of health products has become a priority for regulatory authorities, including the French National Agency for Medicines and Health...
Autores principales: | Belgodère, Laëtitia, Emmerich, Joseph, Albin, Nicolas, Bacon, Trystan, Daynes, Pascale, Vignot, Stéphane, Vial, Thierry, Renaud, Guillaume, Le Saulnier, Carole, Maillard-Couvreur, Corine, Cachet, Mélanie, Veyries, Marie-Laure, Youdarene, Rym, Oualikene-Gonin, Wahiba, Ratignier-Carbonneil, Christelle, Maison, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690943/ https://www.ncbi.nlm.nih.gov/pubmed/38045969 http://dx.doi.org/10.3389/fpubh.2023.1293110 |
Ejemplares similares
-
Collaboration Between Health-Care Professionals, Patients, and National Competent Authorities Is Crucial for Prevention of Health Risks Linked to the Inappropriate Use of Drugs: A Position Paper of the ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)
por: Vignot, Stéphane, et al.
Publicado: (2021) -
Patient and public involvement in the benefit–risk assessment and decision concerning health products: position of the Scientific Advisory Board of the French National Agency for Medicines and Health Products Safety (ANSM)
por: Belgodère, Laëtitia, et al.
Publicado: (2023) -
The French reporting system for drug shortages: description and trends from 2012 to 2018: an observational retrospective study
por: Benhabib, Amine, et al.
Publicado: (2020) -
Regulatory assessment of nano-enabled health products in public health interest. Position of the scientific advisory board of the French National Agency for the Safety of Medicines and Health Products
por: Oualikene-Gonin, Wahiba, et al.
Publicado: (2023) -
Clinical Trial Authorisation: A Final Look Back to Better Appraise the New European Regulation
por: Vignot, Stéphane, et al.
Publicado: (2023)